CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 13:09 (2564 d 18:00 ago) – Posting: # 18887
Views: 7,720

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
44 visitors (0 registered, 44 guests [including 6 identified bots]).
Forum time: 07:09 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5